Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid

American Journal of Pathology

Volumn 178, Issue 1, 2011, Pages 187-197

  Saw, Valerie P J ^a,b   Schmidt, Enno ^c   Offiah, Ifeoma ^a   Galatowicz, Grazyna ^a   Zillikens, Detlef ^c   Dart, John K G ^b   Calder, Virginia L ^a   Daniels, Julie T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; EOTAXIN; INTERLEUKIN 13; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONJUNCTIVA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MUCOUS MEMBRANE PEMPHIGOID; MYOFIBROBLAST; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 79251481507     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.013     Document Type: Article

References (43)

1. Ahmed M, Zein G, Khawaja F, Foster CS: Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res 2004, 23:579-592 (Pubitemid 39243967)
2. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtschig G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost-Squarcioni C, Rogers RS III, Setterfield JF, West DP, Wojnarowska F, Woodley DT, Yancey KB, Zillikens D, Zone JJ: The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002, 138:370-379
3. Black AP, Wojnarowska F, Ogg GS: Role of T cells in the pathogenesis of mucous membrane pemphigoid. Expert Rev Dermatol 2006, 1:25-30
4. Hardy KM, Perry HO, Pingree GC, Kirby TJ Jr: Benign mucous membrane pemphigoid. Arch Dermatol 1971, 104:467-475
5. Mondino BJ, Brown SI, Lempert S, Jenkins MS: The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. Ophthalmology 1979, 86:543-555
6. Mondino BJ, Brown SI: Ocular cicatricial pemphigoid. Ophthalmology 1981, 88:95-100
7. Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS: The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology 2002, 109:111-118 (Pubitemid 34027432)
8. Saw VP, Dart JK, Rauz S, Ramsay A, Bunce C, Xing W, Maddison PG, Phillips M: Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes. Ophthalmology 2008, 115:253-261
9. Bernauer W, Wright P, Dart JK, Leonard JN, Lightman S: Cytokines in the conjunctiva of acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis. Graefes Arch Clin Exp Ophthalmol 1993, 231:563-570 (Pubitemid 23338320)
10. Elder MJ: The role of cytokines in chronic progressive conjunctival cicatrisation. Dev Ophthalmol 1997, 28:159-175
11. Setterfield J, Shirlaw PJ, Bhogal BS, Tilling K, Challacombe SJ, Black MM: Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity. Br J Dermatol 1999, 140:645-650 (Pubitemid 29191382)
12. Stramer BM, Mori R, andMartin P: The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair J Invest Dermatol 2007, 127:1009-1017
13. Ramos C, Montano M, Garcia-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A: Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 2001, 24:591-598 (Pubitemid 32442767)
14. Schuttert JB, Liu MH, Gliem N, Fiedler GM, Zopf S, Mayer C, Muller GA, Grunewald RW: Human renal fibroblasts derived from normal and fibrotic kidneys show differences in increase of extracellular matrix synthesis and cell proliferation upon angiotensin II exposure. Pflugers Arch 2003, 446:387-393
15. Trojanowska M: What did we learn by studying scleroderma fibroblasts? Clin Exp Rheumatol 2004, 22:S59-S63
16. Razzaque MS, Foster CS, Ahmed AR: Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003, 44:1616-1621 (Pubitemid 36378589)
17. Razzaque MS, Foster CS, Ahmed AR: Role of macrophage migration inhibitory factor in conjunctival pathology in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2004, 45:1174-1181
18. Roat MI, Sossi G, Lo CY, andThoft RA: Hyperproliferation of conjunctival fibroblasts from patients with cicatricial pemphigoid. Arch Ophthalmol 1989, 107:1064-1067
19. Thorne JE, Anhalt GJ, Jabs DA: Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 2004, 111:45-52
20. Schmidt E, Skrobek C, Kromminga A, Hashimoto T, Messer G, Brocker EB, Yancey KB, Zillikens D: Cicatricial pemphigoid: igA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol 2001, 145:778-783
21. Lazarova Z, Sitaru C, Zillikens D, Yancey KB: Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid. J Am Acad Dermatol 2004, 51:886-892 (Pubitemid 39593002)
22. Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, Brocker EB, Hashimoto T: A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996, 106:1333-1338 (Pubitemid 26194248)
23. Broadway D: Drug-induced conjunctival cicatrisation. Dev Ophthalmol 1997, 28:86-101
24. Khaw PT, Ward S, Porter A, Grierson I, Hitchings RA, Rice NS: The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts. Invest Ophthalmol Vis Sci 1992, 33:2043-2052
25. Mazure A, Grierson I: In vitro studies of the contractility of cell types involved in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1992, 33:3407-3416
26. Saw VP, Offiah I, Dart RJ, Galatowicz G, Dart JK, Daniels JT, Calder VL: Conjunctival interleukin-13 expression in mucous membrane pemphigoid and functional effects of interleukin-13 on conjunctival fibroblasts in vitro. Am J Pathol 2009, 175:2406-2415
27. Saw VP, Dart RJ, Galatowicz G, Daniels JT, Dart JK, Calder VL: Tumor necrosis factor-alpha in ocular mucous membrane pemphigoid and its effect on conjunctival fibroblasts. Invest Ophthalmol Vis Sci 2009, 50:5310-5317
28. Caproni M, Calzolari A, Giomi B, Santucci M, Ficarra G, Fabbri P: IL-4. IL-5, TGF-beta1 and IFN-gamma mRNAs detected by a new in situ amplification system in cicatricial pemphigoid. Exp Dermatol 2002, 11:421-427
29. Garrett Q, Khaw PT, Blalock TD, Schultz GS, Grotendorst GR, Daniels JT: Involvement of CTGF in TGF-beta1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci 2004, 45:1109-1116
30. Abraham DJ, Eckes B, Rajkumar V, Krieg T: New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 2007, 9:136-143
31. Sullivan DE, Ferris M, Pociask D, Brody AR: Tumor necrosis factoralpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol 2005, 32:342-349
32. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363
33. Vaughan MB, Howard EW, Tomasek JJ: Transforming growth factorbeta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 2000, 257:180-189
34. Radisky DC, LaBarge MA: Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell 2008, 2:511-512
35. Daniels JT, Cambrey AD, Occleston NL, Garrett Q, Tarnuzzer RW, Schultz GS, Khaw PT: Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. Invest Ophthalmol Vis Sci 2003, 44:1104-1110
36. Li DQ, Lee SB, Gunja-Smith Z, Liu Y, Solomon A, Meller D, Tseng SC: Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch Ophthalmol 2001, 119:71-80
37. Wong TT, Sethi C, Daniels JT, Limb GA, Murphy G, Khaw PT: Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol 2002, 47:239-256 (Pubitemid 34575357)
38. Wong TT, Mead AL, Khaw PT: Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci 2003, 44:1097-1103
39. Rieder F, Brenmoehl J, Leeb S, Scholmerich J, Rogler G: Wound healing and fibrosis in intestinal disease. Gut 2007, 56:130-139
40. Corriveau MP, Boufaied I, Lessard J, Chabaud S, Senecal JL, Grodzicky T, Chartier S, Raymond Y, Moulin VJ: The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach. J Pathol 2009, 217:534-42
41. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH: Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004, 113:243-252
42. Karlson TD, Whiting CV, Bland PW: Proinflammatory cytokine synthesis by mucosal fibroblasts from mouse colitis is enhanced by interferon-γ- mediated up-regulation of CD40 signalling. Clin Exp Immunol 2007, 147:313-323
43. Larsson O, Diebold D, Fan D, Peterson M, Nho RS, Bitterman PB, Henke CA: Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS ONE 2008, 3:e3220